FDA Directs Drugmakers To Make Drugs Less Confusing
The U.S. Food and Drug Administration on Thursday released new draft guidelines on how drugmakers should design and test their products to minimize confusion, medication error and overdose deaths....To view the full article, register now.
Already a subscriber? Click here to view full article